Tea Polyphenols in Chemoprevention of Prostate Cancer

茶多酚对前列腺癌的化学预防作用

基本信息

项目摘要

The anticarcinogenic potential of green (GT) and black tea (BT) has been demonstrated in many animal and in vitro cell culture studies. Tea polyphenols, such as epigallocatechin gallate (EGCG) and theaflavins, inhibit cell growth through a variety of mechanisms such as antioxidant activity, alteration of redox-sensitive signal transduction pathways (nuclear factor-kappa B, activator protein 1, mitogen-activated protein kinase) and inhibition of insulin-like growth factor (IGF-1) leading to the inhibition of proliferation, induction of apoptosis, cell cycle arrest as well as inhibition of angiogenesis. However most cell culture and animal studies have been performed with higher concentrations than achievable in humans. It is not clear whether effects observed in animal and cell culture studies can be applied to human studies. Therefore, the overall goal of this study is to perform a phase II clinical intervention trial to investigate whether the consumption of a green tea supplement (Polyphenon E) equivalent to 6 cups of GT or 6 cups of BT for 8 weeks prior to prostatectomy will decrease oxidative stress, alter signaling pathways leading to an inhibition of proliferation and increase of apoptosis in the prostate. We will use immunohistochemistry to determine the apoptotic index and protein expression of Ki67, Bax, Bcl-2, NFkB and concentration of 8-hydroxydeoxyguanosine in sections of equal morphological changes of adenocarcinoma in the human prostate. Serum prostate specific antigen and IGF-1/IGFBP-3 will be determined using chemiluminescent analysis. Since in vivo polyphenols and theaflavins are subject to extensive endogenous and colonic metabolism we propose that metabolites contribute to the chemopreventive effect of GT and BT. We will use high performance liquid chromatography with coularray electrochemical detection as well as mass spectrorrietry (MS) and gas chromatography/ MS to determine the concentrations of polyphenols, theaflavins and six different endogenous and colonic metabo- lites in the prostate, serum and urine of the participants of our tea intervention trial. We will also use the serum collected before and after the tea intervention to be tested in our ex vivo bioassay in LNCaP prostate cancer cells. Finally we will determine the effect of the six metabolites on apoptosis, Bax/Bcl-2 and NFkB- DNA binding after tumor necrosis factor alpha stimulation in LNCaP cells. The results will assist in designing dietary supplements for chemoprevention of early stages of prostate cancer or during watchful waiting.
绿茶(GT)和红茶(BT)的抗癌潜力已在许多动物和动物实验中得到证实

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.
  • DOI:
    10.1080/01635581.2012.661514
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wang P;Heber D;Henning SM
  • 通讯作者:
    Henning SM
Epigenetic effects of green tea polyphenols in cancer.
绿茶多酚在癌症中的表观遗传作用。
  • DOI:
    10.2217/epi.13.57
  • 发表时间:
    2013-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Henning SM;Wang P;Carpenter CL;Heber D
  • 通讯作者:
    Heber D
Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols.
  • DOI:
    10.1371/journal.pone.0010202
  • 发表时间:
    2010-04-16
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Wang P;Henning SM;Heber D
  • 通讯作者:
    Heber D
Chemopreventive effects of tea in prostate cancer: green tea versus black tea.
  • DOI:
    10.1002/mnfr.201000648
  • 发表时间:
    2011-06
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Henning, Susanne M.;Wang, Piwen;Heber, David
  • 通讯作者:
    Heber, David
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susanne Margarete Henning其他文献

Susanne Margarete Henning的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susanne Margarete Henning', 18)}}的其他基金

Quercetin to enhance the bioavailability and activity of green tea polyphenols
槲皮素增强绿茶多酚的生物利用度和活性
  • 批准号:
    8512879
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
Quercetin to enhance the bioavailability and activity of green tea polyphenols
槲皮素增强绿茶多酚的生物利用度和活性
  • 批准号:
    8641331
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
Combined use of green tea and quercetin in prostate cancer
绿茶和槲皮素联合使用治疗前列腺癌
  • 批准号:
    8047388
  • 财政年份:
    2011
  • 资助金额:
    $ 25.63万
  • 项目类别:
Combined use of green tea and quercetin in prostate cancer
绿茶和槲皮素联合使用治疗前列腺癌
  • 批准号:
    8215640
  • 财政年份:
    2011
  • 资助金额:
    $ 25.63万
  • 项目类别:
Tea Polyphenols in Chemoprevention of Prostate Cancer
茶多酚对前列腺癌的化学预防作用
  • 批准号:
    7342127
  • 财政年份:
    2007
  • 资助金额:
    $ 25.63万
  • 项目类别:
Tea Polyphenols in Chemoprevention of Prostate Cancer
茶多酚对前列腺癌的化学预防作用
  • 批准号:
    7208668
  • 财政年份:
    2007
  • 资助金额:
    $ 25.63万
  • 项目类别:
Tea Polyphenols in Chemoprevention of Prostate Cancer
茶多酚对前列腺癌的化学预防作用
  • 批准号:
    7738517
  • 财政年份:
    2007
  • 资助金额:
    $ 25.63万
  • 项目类别:
Tea Polyphenols in Chemoprevention of Prostate Cancer
茶多酚对前列腺癌的化学预防作用
  • 批准号:
    7532783
  • 财政年份:
    2007
  • 资助金额:
    $ 25.63万
  • 项目类别:
Bioavailability of Tea Polyphenols in Prostate Cancer
茶多酚在前列腺癌中的生物利用度
  • 批准号:
    6515059
  • 财政年份:
    2001
  • 资助金额:
    $ 25.63万
  • 项目类别:
Bioavailability of Tea Polyphenols in Prostate Cancer
茶多酚在前列腺癌中的生物利用度
  • 批准号:
    6334562
  • 财政年份:
    2001
  • 资助金额:
    $ 25.63万
  • 项目类别:

相似海外基金

6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10305569
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10488244
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10488242
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10488237
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10305565
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10305568
  • 财政年份:
    2021
  • 资助金额:
    $ 25.63万
  • 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
  • 批准号:
    1903855
  • 财政年份:
    2019
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了